findmyKOL
Clinical trialNCT04109482TerminatedPhase 1/PHASE2Interventional

Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN.

SponsorMustang BioEnrollment3Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A phase 1/2 study to assess the safety and efficacy of MB-102 in patients with relapsed or refractory BPDCN
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope Medical Center

    Duarte, California, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Duke University

    Durham, North Carolina, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cyclophosphamide →Fludarabine →MB-102
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Feb 2020
Primary completion
17 May 2023
Completion
17 May 2023
Last update posted
22 Jul 2024
Registered enrollment
3
Registry id
NCT04109482
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.